 METRONOMIC TREATMENT WITH DAILY ORAL VINORELBINE AS FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH ADVANCEDMETASTATIC HORMONE RECEPTOR POSITIVE HRHUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE HER2- BREAST CANCER: 